US Firm to Trial Bird Flu Vaccine in Indonesia, Hong Kong (Indonesia)
This article was originally published in PharmAsia News
U.S.-based Baxter Healthcare will conduct clinical trials beginning in July 2007 in Singapore and Hong Kong to develop an avian flu vaccine. The trials will use an avian flu viral strain from Indonesia. Baxter has an agreement with the Indonesian government to deliver a human bird flu vaccine to that country. Indonesia plans to purchase or produce around 20 million vaccine doses, enough to inoculate 10 percent of the population during a pandemic, said Indonesian Health Minister Siti Fadilah Supari. (Click here for more
You may also be interested in...
ODAC's 17-18 June discussion of pediatric development plans for four investigational oncology agents will serve as a trial run of the technology platform and logistics for any future application-specific virtual advisory committee meeting, but without the stress associated with a pending application and a user fee deadline.
Vibostolimab is less advanced than Roche’s competing tiragolumab, but Merck thinks the combo of its anti-TIGIT and Keytruda will offer a better therapeutic profile.
Ambitious efforts to make the EU more resilient to future challenges, such as health threats, drug supply problems, scientific advances and growing medicine costs, have taken a step forward with the publication of a roadmap for a wide-ranging Pharmaceutical Strategy to be adopted by the European Commission later in the year.